These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 8289507

  • 21. High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: benefit for selected patients.
    Fernández-Hidalgo OA, Vanaclocha V, Vieitez JM, Aristu JJ, Rebollo J, Gúrpide A, Aramendía JM, Moreno-Palanques R, Martín-Algarra S, Subirá ML, Brugarolas A.
    Bone Marrow Transplant; 1996 Jul; 18(1):143-9. PubMed ID: 8832007
    [Abstract] [Full Text] [Related]

  • 22. [Accelerated hyperfractionation in the treatment of malignant glioma].
    Sugawara T, Nakazawa M, Mizutani Y, Hyodoh H.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Mar 25; 54(4):278-85. PubMed ID: 8177703
    [Abstract] [Full Text] [Related]

  • 23. Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma.
    Alexander A, Murtha A, Abdulkarim B, Mehta V, Wheatley M, Murray B, Riauka T, Hanson J, Fulton D, McEwan A, Roa W.
    Clin Invest Med; 2006 Oct 25; 29(5):301-11. PubMed ID: 17144440
    [Abstract] [Full Text] [Related]

  • 24. Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM).
    Combs SE, Widmer V, Thilmann C, Hof H, Debus J, Schulz-Ertner D.
    Cancer; 2005 Nov 15; 104(10):2168-73. PubMed ID: 16220556
    [Abstract] [Full Text] [Related]

  • 25. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.
    Attenello FJ, Mukherjee D, Datoo G, McGirt MJ, Bohan E, Weingart JD, Olivi A, Quinones-Hinojosa A, Brem H.
    Ann Surg Oncol; 2008 Oct 15; 15(10):2887-93. PubMed ID: 18636295
    [Abstract] [Full Text] [Related]

  • 26. HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival.
    Harrow S, Papanastassiou V, Harland J, Mabbs R, Petty R, Fraser M, Hadley D, Patterson J, Brown SM, Rampling R.
    Gene Ther; 2004 Nov 15; 11(22):1648-58. PubMed ID: 15334111
    [Abstract] [Full Text] [Related]

  • 27. Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas.
    Fine HA, Wen PY, Maher EA, Viscosi E, Batchelor T, Lakhani N, Figg WD, Purow BW, Borkowf CB.
    J Clin Oncol; 2003 Jun 15; 21(12):2299-304. PubMed ID: 12805330
    [Abstract] [Full Text] [Related]

  • 28. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas.
    Li X, Jin H, Lu Y, Oh J, Chang S, Nelson SJ.
    NMR Biomed; 2004 Feb 15; 17(1):10-20. PubMed ID: 15011246
    [Abstract] [Full Text] [Related]

  • 29. Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma.
    Odrazka K, Petera J, Kohlova T, Dolezel M, Vaculikova M, Zouhar M, Malek V, Hobza V, Latr I, Nemecek S, Sercl M, Ryska P, Blaha M, Cermakova E.
    Strahlenther Onkol; 2003 Sep 15; 179(9):615-9. PubMed ID: 14628127
    [Abstract] [Full Text] [Related]

  • 30. [Radio-chemotherapy of inoperable malignant brain gliomas].
    Sciacero P, Cugini A, Geda C, Andreotti M, Ferrari G.
    Radiol Med; 1987 Sep 15; 73(1-2):96-8. PubMed ID: 3809641
    [Abstract] [Full Text] [Related]

  • 31. [The treatment of adult glioma is multiphasic].
    Mäenpää HO.
    Duodecim; 2010 Sep 15; 126(14):1669-75. PubMed ID: 20804085
    [Abstract] [Full Text] [Related]

  • 32. Characterization and outcomes of infratentorial malignant glioma: a population-based study using the Surveillance Epidemiology and End-Results database.
    Rineer J, Schreiber D, Choi K, Rotman M.
    Radiother Oncol; 2010 Jun 15; 95(3):321-6. PubMed ID: 20451276
    [Abstract] [Full Text] [Related]

  • 33. [Treatment of malignant brain tumor].
    Kubo O, Takakura K.
    Gan To Kagaku Ryoho; 1994 Aug 15; 21(10):1583-92. PubMed ID: 8060132
    [Abstract] [Full Text] [Related]

  • 34. [Response factors in the treatment of malignant gliomas in the adult (author's transl)].
    Guérin J, Maire JP, Célerier D, Desplat A, Caudry M, Leman P.
    Neurochirurgie; 1981 Aug 15; 27(5):305-14. PubMed ID: 7335135
    [Abstract] [Full Text] [Related]

  • 35. Malignant glioma management.
    Salcman M.
    Neurosurg Clin N Am; 1990 Jan 15; 1(1):49-63. PubMed ID: 2135973
    [Abstract] [Full Text] [Related]

  • 36. [Usefulness of the antisense and triplex anti-IGF-1 techniques for postoperative cellular gene therapy of malignant gliomas expressing IGF-1].
    Kasprzak HA, Trojan J, Bierwagen M, Kopiński P, Jarocki P, Bartczak K, Czapiewska J.
    Neurol Neurochir Pol; 2006 Jan 15; 40(6):509-15; discussion 516. PubMed ID: 17199177
    [Abstract] [Full Text] [Related]

  • 37. Preliminary clinical trial of immunotherapy for malignant glioma.
    Ingram M, Shelden CH, Jacques S, Skillen RG, Bradley WG, Techy GB, Freshwater DB, Abts RM, Rand RW.
    J Biol Response Mod; 1987 Oct 15; 6(5):489-98. PubMed ID: 3316510
    [Abstract] [Full Text] [Related]

  • 38. [Combined modality treatment of malignant glioma in adults].
    Bauer B, Bretschneider T, Kittner KH.
    Radiobiol Radiother (Berl); 1986 Oct 15; 27(3):287-95. PubMed ID: 3763837
    [No Abstract] [Full Text] [Related]

  • 39. Treatment of infants with malignant gliomas: the Pediatric Oncology Group experience.
    Duffner PK, Krischer JP, Burger PC, Cohen ME, Backstrom JW, Horowitz ME, Sanford RA, Friedman HS, Kun LE.
    J Neurooncol; 1996 Oct 15; 28(2-3):245-56. PubMed ID: 8832466
    [Abstract] [Full Text] [Related]

  • 40. Interleukin-2 (IL-2) in the treatment of malignant brain tumors (glioblastomas).
    Dănăilă L, Ghyka G, Ursaciuc C.
    Rom J Neurol Psychiatry; 1993 Oct 15; 31(3-4):195-206. PubMed ID: 8011483
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.